Bei ya Targeted Therapy (Trastuzumab / Imatinib course) nje ya nchi (2026)
Targeted Therapy (Trastuzumab / Imatinib course) inagharimu kuanzia takriban $8,200 nchini India hadi $32,000 nchini Ujerumani. Bei za kawaida za hospitali kutoka rekodi 72 za bei katika nchi 9. Chagua nchi ili kuona hospitali zake, madaktari na hatua za visa.
- Siku 14 kupona kabisa
- 9 nchi zilizolinganishwa
Bei hizi ni viwango vya bei za hospitali kutoka hifadhidata yetu, si bei ya mwisho. Jinsi tunavyothibitisha
Kadiria gharama yako yote
Chagua machaguo yako. Bei itabadilika papo hapo.
Kifurushi cha hospitali = kiwango cha bei ya kawaida kutoka bei za hospitali 8.
Machaguo ya chumba na kifaa (implant) yanatumia makadirio ya jumla (kad.). Chakula ni takriban $15 kwa mtu kwa siku. Nauli za ndege hazijajumuishwa.
Pata bei halisi 3 kwa makadirio hayaHospitali bora za Targeted Therapy (Trastuzumab / Imatinib course) kwa nchi
Jinsi tunavyopanga orodhaZimepangwa kwa uthibitisho, ukadiriaji wa wagonjwa na idadi ya maoni, kisha bei.
-
1 Indraprastha Apollo HospitalNew Delhi · India · ISO 9001 · JCI · NABH · ★ 4.9Kuanzia$4,410$4,410 – $11,750 Madaktari 2 wameorodheshwa Imethibitishwa na JCI -
2 Bumrungrad InternationalBangkok · Thailand · HA · ISO 9001 · JCI · ★ 4.8Kuanzia$5,660$5,660 – $15,110 Imethibitishwa na JCI -
3 Asan Medical CenterSeoul · South Korea · ISO 9001 · JCI · KOIHA · ★ 4.8Kuanzia$8,210$8,210 – $21,900 Madaktari 21 wameorodheshwa Imethibitishwa na JCI -
4 Cleveland Clinic Abu DhabiAbu Dhabi · United Arab Emirates · DHA · DOH · JCI · ★ 4.7Kuanzia$9,370$9,370 – $24,970 Imethibitishwa na JCI -
5 Mount Elizabeth HospitalSingapore · Singapore · ISO 9001 · JCI · ★ 4.7Kuanzia$10,730$10,730 – $28,610 Imethibitishwa na JCI -
6 Acıbadem Maslak HospitalIstanbul · Turkey · ISO 9001 · JCI · ★ 4.6Kuanzia$6,600$6,600 – $17,590 Imethibitishwa na JCI
Pata ripoti ya gharama na mipango ya Targeted Therapy (Trastuzumab / Imatinib course)
PDF ya bure iliyotayarishwa kwa bei zilizotangazwa leo. Ihifadhi, ichapishe au uwatumie familia yako kwenye WhatsApp.
Kilichomo ndani
- Bei kwa nchi, jiji na hospitali, zikilinganishwa na za nyumbani
- Bajeti kamili ya safari: matibabu, malazi, chakula, visa
- Ratiba ya siku kwa siku na hatua za kupona
- Muhtasari wa visa, orodha ya maandalizi na maswali ya kuuliza
- Matibabu (bei ya kawaida iliyotangazwa) 87% $8,200
- Malazi 7% $650
- Chakula 4% $400
- Usafiri wa ndani 1% $100
- Ada za visa 2% $150
- Jumla ya makadirio$9,500
Chanzo: medcasts.com · bei kufikia Mei 2026
Pata maoni ya pili bila malipo ndani ya saa 48.
Tuma picha za vipimo (scans) na taarifa zako. Mtaalamu mwandamizi atazipitia na kujibu kwa maandishi.
Madaktari bora wa upasuaji wa Targeted Therapy (Trastuzumab / Imatinib course)
Bei za Targeted Therapy (Trastuzumab / Imatinib course) kwa nchi
Bei ya kawaida ya hospitali kwa kila nchi, kutoka rekodi 72 za bei katika hifadhidata ya Medcasts.
Kawaida bei ya hospitali inajumuisha nini
- Daktari wa upasuaji, ganzi na chumba cha upasuaji
- Kukaa kwako hospitalini na huduma za wauguzi
- Vipimo vya kawaida na dawa wakati wa kukaa hospitalini
- Msaidizi wa Medcasts bila malipo, msaada wa barua ya visa na mipango ya kuchukuliwa uwanja wa ndege
- Havijajumuishwa: nauli za ndege na hoteli baada ya kutoka hospitalini
Kila bei tunayotuma inaonyesha kilichojumuishwa na kisichojumuishwa, mstari kwa mstari.
Mpango wako wa kupona
- Day 1Infusion or first tablets in a day unit; fever, chills or rash can occur and are treated at once. You go home the same day.
- Weeks 1-4Tiredness, diarrhoea, swelling or nausea may appear. Blood tests check counts and liver function.
- Months 2-3First response assessment with scans or blood markers; the plan is confirmed or adjusted.
- Months 6 onwardsTreatment continues for the planned duration with regular heart checks, bloods and scans.
Muda wa visa ya matibabu kwa kila nchi
Muda wa kushughulikia visa kwa kila nchi
Tunatuma barua ya mwaliko wa hospitali ndani ya saa 24 baada ya uamuzi wako. Angalia visa yako
Kuhusu Targeted Therapy (Trastuzumab / Imatinib course)
This is a course of medicine rather than an operation. Trastuzumab is given as an infusion or injection at a day-care unit, usually every three weeks, while imatinib is a tablet taken daily at home. Treatment may run for months or years, sometimes alongside chemotherapy, and the drug and schedule are chosen to match your tumour's test results.
Response depends on whether the target is truly present, the stage of disease, and how well you tolerate the drug. Some people have a lasting response, others develop resistance over time. Side effects differ by drug and can include heart changes with trastuzumab or fluid retention and tiredness with imatinib, so regular monitoring is part of treatment.
Bring full pathology and biomarker reports, such as HER2 or BCR-ABL results, plus your current medicine list. Because treatment continues for a long time, work out in advance who will give each cycle, who will monitor your heart or blood counts, and how you will obtain a reliable supply of the drug at home.
Kwa kawaida inafaa kama
- Tumour or blood test confirming the specific target, such as HER2-positive disease or BCR-ABL-positive leukaemia.
- Adequate heart function for trastuzumab, and acceptable liver and kidney function.
- Willingness to keep regular blood tests, scans and heart checks for the duration.
- A cancer type for which the drug has an established role.
Huenda ukahitaji kusubiri kama
- Target not confirmed by a reliable laboratory test.
- Significantly reduced heart pumping function, which may need cardiology review before trastuzumab.
- Pregnancy or plans to conceive, because these drugs can harm an unborn baby.
- Inability to take the drug consistently or to attend monitoring.
Jinsi ya kujiandaa
- Bring pathology and molecular reports (HER2, BCR-ABL, KIT or similar); the drug is only appropriate if the target is confirmed.
- Have a baseline heart assessment such as an echocardiogram if trastuzumab is planned, plus blood counts, liver and kidney tests.
- Give your doctor a full list of medicines and supplements, as imatinib interacts with several common drugs; change nothing without instruction.
- Agree a plan for how long you will stay abroad and how treatment will continue safely at home.
- Ask about a reliable supply of the same brand or biosimilar for the whole course.
Maswali ya kumuuliza daktari wako wa upasuaji
- Which test confirmed my target, and was it done in an accredited laboratory?
- Is this the original drug or a biosimilar, and is the course length the same as in international guidelines?
- How will my heart, liver and blood counts be monitored, and how often?
- What side effects should prompt me to call urgently, and who answers from abroad?
- What happens if I miss doses or cannot get the drug at home?
- Should this be combined with chemotherapy, surgery or hormone therapy?
Dalili za hatari unapolinganisha hospitali
- Prescribing a targeted drug without seeing target-test results.
- Selling a short 'course' as a complete treatment for a cancer that normally needs long-term or combined therapy.
- No heart monitoring plan when trastuzumab is used.
- Unclear drug origin, batch or storage, or refusal to name the brand.
Maswali kuhusu Targeted Therapy (Trastuzumab / Imatinib course) nje ya nchi
Ni nchi gani yenye bei nafuu zaidi kwa Targeted Therapy (Trastuzumab / Imatinib course)?
Bei za kawaida za hospitali za chini kabisa ziko India ($8,213), Thailand ($10,245), Uturuki ($12,290), kati ya nchi 9 tunazolinganisha.